B

Biora Therapeutics
D

BIOR

2.45000
USD
-0.19
(-7.20%)
Market Closed
Volume
3,613
EPS
0
Div Yield
0
P/E
-0
Market Cap
89,349,266
OverviewSignalsIdeasNews
Related Instruments
    A
    ALKS
    -0.440
    (-1.61%)
    26.860 USD
    AMGN
    2.78
    (0.84%)
    335.22 USD
    B
    BIIB
    -2.500
    (-1.17%)
    210.710 USD
    GILD
    0.470
    (0.62%)
    76.510 USD
    I
    INCY
    -0.680
    (-1.05%)
    64.390 USD
    P
    PBYI
    -0.10000
    (-2.79%)
    3.49000 USD
    REGN
    13.14
    (1.22%)
    1,091.19 USD
    S
    SGEN
    0
    (0%)
    0.000000 USD
    VRTX
    9.75
    (1.97%)
    505.40 USD
    X
    XLRN
    0
    (0%)
    0.000000 USD
    More
News

Title: Biora Therapeutics Inc

Sector: Healthcare
Industry: Biotechnology
Biora Therapeutics Inc is a biotechnology company engaged in developing oral biotherapeutics. Its drug-device combinations could enable new treatment approaches in the delivery of therapeutics in two main areas: Targeted delivery of therapeutics to the site of disease in the gastrointestinal ("GI") tract, which is designed to improve outcomes for patients with Inflammatory Bowel Disease (IBD); and Systemic delivery of biotherapeutics, which are designed to replace injection with needle-free, oral delivery technology.